Catalyst Pharmaceuticals

DividendsCatalyst Pharmaceuticals

CPRX

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

See below the complete and updated table with all dividends paid and declared history, etc

This company has not yet paid dividends.